The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden. [electronic resource]
Producer: 20130228Description: 1471-6 p. digitalISSN:- 1815-7920
- Antitubercular Agents -- pharmacology
- Bacterial Proteins -- genetics
- Base Sequence
- DNA-Directed RNA Polymerases
- Drug Resistance, Bacterial
- Humans
- Limit of Detection
- Microbial Sensitivity Tests
- Microscopy -- methods
- Molecular Sequence Data
- Mycobacterium tuberculosis -- drug effects
- Nucleic Acid Amplification Techniques -- methods
- Real-Time Polymerase Chain Reaction
- Republic of Korea -- epidemiology
- Rifampin -- pharmacology
- Sensitivity and Specificity
- Sputum -- microbiology
- Time Factors
- Tuberculosis -- diagnosis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.